3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
128
Esophageal Neoplasms
127
Esophageal Squamous Cell Carcinoma
77
Adenocarcinoma Of Esophagus
36
Pancreatic Neoplasms
30
Colorectal Neoplasms
25
Carcinoma, Non-Small-Cell Lung
23
Breast Neoplasms
22
Neoplasms
21
Neoplasm Metastasis
19
Ovarian Neoplasms
16
Melanoma
12
Lung Neoplasms
11
Carcinoma, Squamous Cell
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Adenocarcinoma
10
Endometrial Neoplasms
9
Carcinoma, Renal Cell
9
Advanced Gastric Cancer
9
Squamous Cell Carcinoma of Head and Neck
8
Peritoneal Neoplasms
8
Colonic Neoplasms
8
Carcinoma, Ovarian Epithelial
8
Anus Neoplasms
8
Digestive System Neoplasms
7
Prostatic Neoplasms
6
Cholangiocarcinoma
6
Biliary Tract Neoplasms
6
Uterine Cervical Neoplasms
5
Sarcoma
5
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
4
pimonidazole
2
TH 302
2
pembrolizumab
1
inositol trispyrophosphate
1
gadobutrol
1
fluoromisonidazole
1
Tirapazamine
1
Surgical Procedures, Operative
1
Radiotherapy
1
Propofol
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Ipilimumab
1
Injections
1
Gemcitabine
1
Ethiodized Oil
1
Cisplatin
1
Blood Specimen Collection
1
Biopsy
1
AQ4N
1
4-methylbenzenesulfonic acid
1
3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypoxia
×
Paclitaxel
×
Gastrointestinal
×
Clear all
NCT05281003
2023-07-13
HYPERION
Fudan University
Phase 2
Recruiting
128 enrolled